Log in
Enquire now
InnoSkel

InnoSkel

InnoSkel is a therapies for Rare Skeletal Diseases founded in 2020 by Elvire Gouze.

OverviewStructured DataIssuesContributors
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
0
CEO
Elvire Gouze
Elvire Gouze
0
CFO
Alexandre Fabre
Alexandre Fabre
0
Company Operating Status
Active
Country
France
France
0
Crunchbase URL
crunchbase.com/organiz...innoskel
CTO
‌
Sophie Amsellem-Bosq
0
Email Address
contact@innoskel.com
0
Founded Date
2020
0
Founder
Elvire Gouze
Elvire Gouze
0
Full Address
Sophia Antipolis, FR
0
BioParc 2400 Route des Colles 06410 Biot France
0
Headquarters
Nice
Nice
Industry
Gene therapy
Gene therapy
0
Health technology
Health technology
Regenerative medicine
Regenerative medicine
Genetic engineering
Genetic engineering
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Biopharmaceutical
Biopharmaceutical
Technology
Technology
‌
Rare disease
Biology
Biology
•••
Investors
Jeito Capital
Jeito Capital
0
Vida Ventures
Vida Ventures
0
Turenne Groupe
Turenne Groupe
0
Latest Funding Round Date
December 1, 2020
Latest Funding Round Amount (USD)
24,000,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/innoskel
Location
Sophia Antipolis
Sophia Antipolis
Biot, Alpes-Maritimes
Biot, Alpes-Maritimes
0
Number of Employees (Ranges)
1 – 10
0
Phone Number
+33492952970
0
Pitchbook URL
pitchbook.com/profiles...455062-33
Public/Private
Private
Total Funding Amount (USD)
44,000,000
Official Website
innoskel.com

Find more companies like InnoSkel

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.